Selvas AI Inc. (108860.KQ)
- Previous Close
13,680.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 18,400.00 - Volume
0 - Avg. Volume
1,177,373 - Market Cap (intraday)
360.113B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Selvas AI Inc. operates as an artificial intelligence (AI) company in South Korea. The company offers Selvy Note, an AI Voice Record for recognizing the content of conversations such as research, consultation, and meetings; Selvy MediVoice, an AI medical voice recognition that generates medical records during the medical process through voice; Selvy SpeechEdu, an AI training voice recognition for text utilization learning, sentence pronunciation accuracy learning, and sophisticated pronunciation at the phoneme/phonetic level. It also provides odiro, an AI voice content creation solution; Selvy Alrimi, an AI announcement solution to enter the broadcast content as text and the announcement voice can be automatically transmitted at the desired time; Selvy Checkup, an AI disease occurrence probability prediction solution; OnFit, an IoT-based smart fitness/fitness membership management program; Selpub, a cloud-based multimedia eBook; and DIODICT, a mobile electronic dictionary. The company was formerly known as DIOTEK Co., Ltd. and changed its name to Selvas AI Inc. in September 2016. Selvas AI Inc. was founded in 1999 and is based in Seoul, South Korea.
www.selvasai.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 108860.KQ
View MorePerformance Overview: 108860.KQ
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 108860.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 108860.KQ
View MoreValuation Measures
Market Cap
360.11B
Enterprise Value
264.04B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.20
Price/Book (mrq)
2.98
Enterprise Value/Revenue
2.35
Enterprise Value/EBITDA
26.67
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.16%
Return on Assets (ttm)
0.20%
Return on Equity (ttm)
-0.47%
Revenue (ttm)
112.45B
Net Income Avi to Common (ttm)
-5.81B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
115.24B
Total Debt/Equity (mrq)
7.29%
Levered Free Cash Flow (ttm)
-17.01B